Stocks and Investing
Stocks and Investing
Thu, April 4, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, April 3, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Oren Livnat Reiterated (zvra) at Strong Buy and Held Target at $15 on, Apr 3rd, 2024
Oren Livnat of HC Wainwright & Co., Reiterated "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy and Held Target at $15 on, Apr 3rd, 2024.
Oren has made no other calls on ZVRA in the last 4 months.
There are 2 other peers that have a rating on ZVRA. Out of the 2 peers that are also analyzing ZVRA, 0 agree with Oren's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Oren
- Louise Chen of "Cantor Fitzgerald" Reiterated at Buy on, Monday, April 1st, 2024
- Tim Lugo of "William Blair" Initiated at Buy on, Tuesday, March 12th, 2024
Contributing Sources